IPO Trending
MOLBIOEQ / NSE, BSEAllotted

Molbio Diagnostics Limited

Founded in 2000, Molbio Diagnostics Limited is a healthcare company focused on providing fast, accurate, and affordable diagnostic solutions for both infectious and non-communicable diseases. Its key product, the Truenat platform, is a portable PCR-based testing system that can deliver results within an hour, even in remote or low-resource areas, and is used to detect diseases like tuberculosis, COVID-19, hepatitis, HIV, and HPV. The company also offers radiology, digital pathology, and breast health screening solutions through its group entities and partners. It operates five manufacturing facilities across India to produce diagnostic devices, test kits, and portable X-ray systems. With a presence in over 80 countries and a strong distributor network, Molbio serves public health programs, hospitals, and diagnostic labs worldwide, generating revenue from both device sales and recurring test kit usage. As of March 31, 2025, the company had around 1,000 permanent employees along with over 1,500 contract workers.

₹768 - ₹807GMP ₹12670.26x sub
GMP+₹126
Est. Listing Price₹933
Subscription70.26x total demandUpdated 15 Aug 2026, 12:04 PM
QIB186.39x
🔥 Blockbuster Sizzling Demand!Offered: 23,25,146 sh
Nib49.80x
🔥 Blockbuster Sizzling Demand!Offered: 17,43,859 sh
Hnis(10l +)50.82x
🔥 Blockbuster Sizzling Demand!Offered: 11,62,573 sh
Hnis (2-10l)47.76x
🔥 Blockbuster Sizzling Demand!Offered: 5,81,286 sh
Retail12.96x
Hot Bidding (High Profits)Offered: 40,69,004 sh
Employees13.28x
Hot Bidding (High Profits)Offered: 20,520 sh
CategoryOfferedAppliedTimes
QIB23,25,14643,33,82,148186.39x
Nib17,43,8598,68,40,60449.8x
Hnis(10l +)11,62,5735,90,76,59450.82x
Hnis (2-10l)5,81,2862,77,64,01047.76x
Retail40,69,0045,27,19,31812.96x
Employees20,5202,72,46613.28x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB34,973.94187.64186.39x
Fiis13,864.610Open
Fis16,837.590Open
Mutual Funds1,936.760Open
Others2,334.970Open
Retail4,254.45328.3712.96x
Hnis 2+2,240.5646.9147.76x
Hnis 10+4,767.4893.8250.82x
Employees21.991.6613.25x
Application-wise Breakup
CategoryReservedAppliedTimes Sub.
Retail2,26,05625,24,58611.17x
Employees08,879Open
Hnis(10l +)4,61346,45510.07x
Hnis (2-10l)2,3071,06,58946.20x

Molbio Diagnostics Limited IPO Live Subscription Status & Category Bidding Analysis (2026)

Track the live subscription status and investor bidding numbers for Molbio Diagnostics Limited (MOLBIO) IPO. The issue opened for bidding across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Overall, the IPO has been subscribed 70.26x so far. Check real-time grey market demand on our Molbio Diagnostics Limited GMP Page.

QIB CategoryLiveInstitutional
NII / HNI CategoryLiveNon-Institutional
Retail (RII)LiveRetail Investors
Total Subscription70.26xOverall Multiplier

Explore More About Molbio Diagnostics Limited IPO

Frequently Asked Questions (FAQs) - Molbio Diagnostics Limited Subscription